当前位置:产品中心>单抗/多抗

Anti-Human IFN-gamma Reference Antibody|抗人IFN-γ参考抗体(靶标:人干扰素γ)

货号:RB9T37015411
  • 价格:面议
  • 点击数:651
  

产品介绍

产品参数

形态Liquid
宿主种属Human
克隆性Monoclonal
抗体亚型IgG1-lambda
纯度>95% purity as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
浓度5mg/ml
内毒素水平Please contact the lab for this information.
应用ELISA, Bioactivity: FACS, Functional assay, Research in vivo
种属反应性Human
靶标Interferon gamma, IFN-gamma, Immune interferon, IFNG
储存缓冲液0.01M PBS, pH 7.4.
稳定性和储存Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
表达系统Mammalian Cells
登录号P01579
背景信息Emapalumab (NI-0501) is a human monoclonal IgG1 antibody that noncompetitively inhibits IFN-γ. Emapalumab binds with high affinity (Kd= 1.4 pM) to both free IFN-γ as well as IFN-γ bound to its receptor. Emapalumab can be used in research of hemophagocytic lymphohistiocytosis (HLH).<br>• Interferon-γ induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation., PMID:33606996<br/>• Dysregulation in IFN-γ signaling and response: the barricade to tumor immunotherapy., PMID:37275859<br/>• IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption., PMID:31566580<br/>• IFN-<i>γ</i> Contributes to the Immune Mechanisms of Hypertension., PMID:36591357<br/>• Liver type 1 innate lymphoid cells develop locally via an interferon-γ-dependent loop., PMID:33766856<br/>• Parasitic helminths induce fetal-like reversion in the intestinal stem cell niche., PMID:29950724<br/>• IRAK1-regulated IFN-γ signaling induces MDSC to facilitate immune evasion in FGFR1-driven hematological malignancies., PMID:34906138<br/>• Interferon-gamma release assay performance in northeastern Brazil: influence of the IFNG+874 A>T polymorphism., PMID:29787713<br/>• Restraint of IFN-γ expression through a distal silencer CNS-28 for tissue homeostasis., PMID:37040761<br/>• MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer., PMID:33495298<br/>
别名NI-0501, emapalumab-lzsg, 1709815-23-5
备注For research use only. Not suitable for clinical or therapeutic use.